Jonathan Bouchard

Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes

Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol

Reactive Oxygen Species in Inflammation and Tissue Injury

The Economic Value of Specialized Lower-Extremity Medical Care by Podiatric Physicians in the Treatment of Diabetic Foot Ulcers

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

Trends in incidence of total or type 2 diabetes: systematic review

The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes

The Economic Costs of Type 2 Diabetes: A Global Systematic Review

Complementing Insulin Therapy to Achieve Glycemic Control

Mechanisms of diabetes mellitus-induced bone fragility

Sarcopenia: a chronic complication of type 2 diabetes mellitus

Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

AI in health and medicine

SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects

Association Between Glycemic Control and Adverse Outcomes in People With Diabetes Mellitus and Chronic Kidney Disease

Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France

Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database

The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern

Type 2 diabetes

Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

Global burden of liver disease: 2023 update

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

Type 2 diabetes mellitus

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

Chronic Kidney Disease Diagnosis and Management

Artificial Intelligence in Surgery: Promises and Perils

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

Real‐world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Midlife Systemic Inflammation Is Associated With Frailty in Later Life: The ARIC Study

Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes

Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia

Usability Evaluation of a Blood Glucose Monitoring System With a Spill-Resistant Vial, Easier Strip Handling, and Connectivity to a Mobile App

The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology

Reactive Oxygen Species in Metabolic and Inflammatory Signaling

Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis

Pen Devices for Insulin Self-Administration Compared With Needle and Vial

Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia

Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles

Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996–2016

Cost sharing, adherence, and health outcomes in patients with diabetes.

Decreasing incidence of type 2 diabetes mellitus in the United States, 2007–2012: Epidemiologic findings from a large US claims database

Assessment of adherence and healthcare costs of insulin device (FlexPen®) versus conventional vial/syringe

Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods

Association between hypoglycaemic events and fall‐related fractures in Medicare‐covered patients with type 2 diabetes

Does type of bolus insulin matter in the hospital? Retrospective cohort analysis of outcomes between patients receiving analogue versus human insulin

Direct Health Care Costs of Patients With Type 2 Diabetes Within a Privately Insured Employed Population, 2000 and 2005

Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes

Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetes

Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system